CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Low demand is prompting drugmaker Roche to discontinue two of its anti-HIV drugs, AIDSmap.com reports. The company will stop production of its nucleoside reverse transcriptase inhibitor Hivid, also known as ddC, and its protease inhibitor Fortovase. Hivid is rarely prescribed by physicians because studies have shown it can cause peripheral neuropathy in as many as 31% of the HIV patients taking it. Roche's protease inhibitor Fortovase is not as well-tolerated as its other protease drug, Invirase, say company officials. The drugs will be discontinued in 2006 or shortly thereafter.
From our Sponsors
Most Popular
Watch Now: Advocate Channel
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Latest Stories
Queer Youth Negatively Affected by Anti-LGBTQ+ Laws, Debates: Trevor Project Poll
January 20 2023 5:18 PM
Emanuele Crialese on His Autobiographical Coming-of-age Trans Film, L'immensitÃ
January 19 2023 8:02 PM
CPAC's Matt Schlapp & Wife Sued By GOP Staffer For Sex Harassment, Defamation
January 19 2023 5:13 PM
'Elm Street' Star Mark Patton Hospitalized With AIDS Complications, Seeks Help
January 19 2023 9:12 AM